You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Tackling the blind spot of poor-quality medicines in Universal Health Coverage
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, May 2020
|
| DOI | 10.1186/s40545-020-00208-4 |
| Pubmed ID | |
| Authors |
E. S. F. Orubu, C. Ching, M. H. Zaman, V. J. Wirtz |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 29% |
| Rwanda | 1 | 14% |
| Belgium | 1 | 14% |
| United States | 1 | 14% |
| Unknown | 2 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 2 | 29% |
| Practitioners (doctors, other healthcare professionals) | 2 | 29% |
| Science communicators (journalists, bloggers, editors) | 2 | 29% |
| Members of the public | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 93 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 15% |
| Student > Ph. D. Student | 10 | 11% |
| Researcher | 7 | 8% |
| Student > Postgraduate | 5 | 5% |
| Student > Bachelor | 5 | 5% |
| Other | 13 | 14% |
| Unknown | 39 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 15% |
| Nursing and Health Professions | 7 | 8% |
| Business, Management and Accounting | 6 | 6% |
| Unspecified | 5 | 5% |
| Medicine and Dentistry | 4 | 4% |
| Other | 14 | 15% |
| Unknown | 43 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2020.
All research outputs
#6,872,952
of 24,260,998 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#159
of 449 outputs
Outputs of similar age
#137,802
of 389,244 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#13
of 23 outputs
Altmetric has tracked 24,260,998 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 449 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 389,244 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.